Navigation Links
CureFAKtor Pharmaceuticals Demonstrates Novel Focal Adhesion Kinase (FAK) Inhibitor C4 Analogs Inhibited Pancreatic Cancer Tumor Growth as Single Agents
Date:11/14/2011

SAN FRANCISCO, Nov. 14, 2011 /PRNewswire/ -- CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented preclinical research results at the 2011 AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference in San Francisco, California demonstrating that analogs of novel FAK inhibitor CFAK-C4 disrupted FAK-vascular endothelial growth factor receptor 3 (FAK-VEGFR3) interaction and inhibited pancreatic cancer tumor growth at low concentrations as single agents. The research was conducted by CureFAKtor scientists at the Roswell Park Cancer Institute in Buffalo, New York.

In the poster presentation, Development of Novel FAK Inhibitors Targeting the FAK-VEGFR3 Protein-Protein Interaction Site, CureFAKtor Chief Scientific Officer Dr. William Cance and Senior Scientist Dr. Elena Kurenova reported that oral small molecule FAK inhibitor C4 analogs, C9, C10 and C9A, administered as low dose single agents led to 40 to 60 percent reduction in pancreatic tumor growth in vivo after 30 days of treatment in mouse models. The C4 analogs displayed enhanced potency, minimum toxicity and high specificity for the target site. Abstract C124 will be presented on Tuesday, November 15 from 12:30 to 2:30 pm at West Hall, Level One, Moscone Center West.

"These preclinical results of C4 analogs inhibiting pancreatic tumor growth are very promising and add to our existing C4 data," said H. Shep Wild, President and Chief Executive Officer of CureFAKtor Pharmaceuticals. "We know that FAK protects tumors from chemotherapeutic drugs and radiation, allowing the tumor cells to resist these therapies."

CureFAKtor Pharmaceuticals recently presented preclinical research results at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer in Barcelona, Spain demonstrating that FAK inhi
'/>"/>

SOURCE CureFAKtor Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CureFAKtor Pharmaceuticals Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer
2. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
3. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density
4. CureFAKtor Pharmaceuticals to Present at 10th Annual BIO Investor Forum
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, 2015 /PRNewswire/ ... medical device company that has developed and commercialized an ... pain, today announced that Brad Vale , PhD, ... (JJDC), has been appointed to its Board of Directors, ... has over 30 years of experience in developing, commercializing ...
(Date:3/2/2015)... 2, 2015  IGI Laboratories, Inc. (NYSE MKT: IG), a ... results for the fourth quarter and year ended December 31, ... Highlights , Total revenues of $13.7 million in ... the same quarter in 2013 , Total revenues of ... increase of 85% over the same period in 2013 ...
(Date:3/2/2015)...  Intrexon Corporation (NYSE: XON ), ... fourth quarter and full year results for 2014.  ... , Acquired ActoGeniX, a European clinical stage ... therapeutics and other innovative products.  Its proprietary TopAct™ ... ( Lactococcus lactis ) to generate biologically-contained ActoBiotics™ ...
Breaking Medicine Technology:Nevro Appoints Dr. Brad Vale to its Board of Directors 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24
... 5, 2011 Varian Medical Systems, Inc. (NYSE: ... CEO and member of the Board of Directors for Smith ... management in global medical device businesses, has been appointed to ... Board of Directors also increased its size from nine to ...
... healthcare supply chain experts will showcase best practices for ... hospitals—supply chain costs—at the GHX booth during the AHRMM11 ... taking on a more strategic role in hospitals across ... also to provide data visibility that can dramatically impact ...
Cached Medicine Technology:GHX Spotlights Supply Chain Role in Reducing Costs and Improving Patient Care at the AHRMM11 Annual Conference 2GHX Spotlights Supply Chain Role in Reducing Costs and Improving Patient Care at the AHRMM11 Annual Conference 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 Sponsors of ... have an abundance of significant proposed changes to sift ... and preliminary 2016 Call Letter released Feb. 20. The ... they will vary considerably with the type and location ... to analyze and comment on them before CMS issues ...
(Date:3/3/2015)... 03, 2015 AliCare Medical Management ... management programs and a member of the Amalgamated ... Julie O’Brien as President. O’Brien formerly served as ... In her new role, she will continue with ... of AMM’s call center operations, including clinical services, ...
(Date:3/3/2015)... Aurora Fit Body Boot Camp will ... observe the opening of the indoor fitness boot camp and ... event will be held on March 21 from 8am to ... opening will feature free boot camp demonstrations, local small business ... the world’s most popular and fastest growing indoor fitness ...
(Date:3/3/2015)... March 03, 2015 Join colleagues from ... Phoenix, Arizona, June 7-10. The Learning Summit is a ... colleagues, discuss issues, and explore strategies for focusing entire ... Jenkins, senior research associate at the Community College Research ... on Sunday evening. , Monday through Wednesday, the program ...
(Date:3/2/2015)... Calif. (PRWEB) March 02, 2015 ... (R-San Luis Obispo), in partnership with the California ... Rare Disorders (NORD), presented an Assembly resolution recognizing ... the families and healthcare professionals caring for millions ... CHI is a nonprofit, public policy research organization, ...
Breaking Medicine News(10 mins):Health News:March 12 Webinar to Analyze Implications of CMS’s ’45-Day Notice’ and 2016 Call Letter for MA and Part D Plans 2Health News:Julie O'Brien Named President of AliCare Medical Management 2Health News:Julie O'Brien Named President of AliCare Medical Management 3Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 2Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 3Health News:Register Today for the League for Innovation in the Community College’s Learning Summit 2015 2Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 2Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 3
... nutrition school, NEW YORK, Feb. 13 Andrew ... Hyman. Mehmet Oz. Michael Jacobson.,Neal Barnard. Walter Willett., ... all educators at The,Institute for Integrative Nutrition, and they,ve ... instructor Joshua Rosenthal to develop,students into health counselors. These ...
... Winner Medical Group,Inc. (OTC Bulletin Board: WMDG; "Winner Medical"), ... of fiscal year 2008,ended December 31, 2007. The Company,s ... the United States Securities and Exchange,Commission., First ... $19.33 million, a 21.73% year-on-year ...
... 13 , - Awardees Set Example for Innovation ... Foundation has announced today that it has committed a,total ... the,world in support of initiatives that promote the work ... recipient programs were,selected from over 150 applicants worldwide for ...
... ST. PETERSBURG, Fla., Feb. 13 , WHAT/WHO: FairWarning, Inc. a provider of healthcare privacy ... with HIMSS, will host a Webinar ... Compliance Challenges. The Webinar will feature John Wade, ... St. Luke,s Health System and ...
... Feb. 13 West Pharmaceutical,Services, Inc. (NYSE: WST ... financial results before the market opens on Thursday, February ... discuss the results and,business expectations at 9:00 a.m. Eastern ... or (210) 839-8506. The passcode is WST., A ...
... of Information Clouds,the Picture, MIAMI, Feb. 13 ... their biggest healthcare concern and find,information about the cost ... and confusing. They are paying close attention to presidential,candidates ... candidates,about the bottom line cost for them and for ...
Cached Medicine News:Health News:Institute for Integrative Nutrition, Joshua Rosenthal Attract Nation's Top Health, Wellness Experts 2Health News:Institute for Integrative Nutrition, Joshua Rosenthal Attract Nation's Top Health, Wellness Experts 3Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 2Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 3Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 4Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 5Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 6Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 7Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 8Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 9Health News:Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars 2Health News:Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars 3Health News:FairWarning to Host Webinar Featuring HIMSS Chairman and Healthcare Executive from PricewaterhouseCoopers on Electronic Health Record Privacy and Compliance Challenges 2Health News:West to Host 2007 Fourth Quarter Conference Call 2Health News:New Poll Gauges South Florida's Views on Health Care 2Health News:New Poll Gauges South Florida's Views on Health Care 3Health News:New Poll Gauges South Florida's Views on Health Care 4Health News:New Poll Gauges South Florida's Views on Health Care 5
... on decades of experience, the SSD-1000 is ... system. It uses our advanced technologies and ... Using the same technology as our more ... capabilities in a compact and mobile setting., ...
... Harmonic Echo technology constructs images using ... less artifacts and noise than fundamental-frequency ... technology to transmit distortion-free, fundamental-frequency ultrasound ... beam is a pure sinusoidal wave, ...
... you new options for skin wound repair. ... only to hold closed easily approximated skin ... punctures from minimally invasive surgery, and simple, ... be used in conjunction with, but not ...
The first Ethyl-2-Cyanoacrylate tissue adhesive in a tube that is more economical than sutures!...
Medicine Products: